Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 90.57 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $559.20 million which beat the analyst consensus estimate of $544.38 million by 2.72 percent. This is a 12.72 percent increase over sales of $496.10 million the same period last year.
Surgery Partners Q3 EPS $(0.05) Beats $(0.06) Estimate, Sales $559.20M Beat $544.38M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 90.57 percent increase over losses of $(0.53) per share from
